Montelukast: a review of its therapeutic potential in persistent asthma.
about
Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthmaRecent advances in the management of asthma using leukotriene modifiersG-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveChemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus InhibitionConcentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionA review of montelukast in the treatment of asthma and allergic rhinitis.Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthmaThe G protein-coupled receptors: pharmacogenetics and disease.Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialTreatment heterogeneity in asthma: genetics of response to leukotriene modifiers.Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response.CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.Maximum Time of the Effect of Antileukotriene - Zileuton in Treatment of Patients with Bronchial Asthma.Commentary: Mutual interaction of basophils and T cells in chronic inflammatory diseases.Comparison of Glucocorticoid (Budesonide) and Antileukotriene (Montelukast) Effect in Patients with Bronchial Asthma Determined with Body Plethysmography.A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.Asthma control and patient satisfaction among early pediatric users of montelukast.The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactions.
P2860
Q24201133-C8BE0B80-A273-4D26-9175-CB4317B11417Q28166742-FE51C72B-F28C-4B93-BD88-4D047B20F772Q28212087-CC751984-DFA8-4ED1-8FC5-8328E661B152Q28833828-C1B98857-F943-496D-A2D9-CFF2C075C5C0Q33677296-2D717397-FFB2-4C81-999C-48D92770D1A0Q33757657-88E95AC3-B668-482F-BB93-6D8C147BD182Q35688199-D8F04077-2764-4CBA-9D10-8CC769F2DB2FQ36217677-1B86C832-724F-40C3-BD8C-6128F92F8560Q36310854-595609FC-371B-4D2D-8E93-9B98CE1E3D8FQ36351758-8B10A66B-0065-47F3-ADF7-A30401D93964Q36775615-F1768F8C-7B31-4864-8A2F-B239B30E026DQ37094329-860099CC-4B85-4DA2-972D-DFE78F79A2A5Q37140406-03FFF68F-6FDE-4F22-BB24-C247A72FDE88Q38903489-CA743AE9-5E99-4EC6-9E3C-75A7015A9CBAQ38967122-D0F388D1-9534-492A-A40C-736A5B6C5F8AQ39966532-FC74B326-AB18-421A-A1F3-6A583576EE6CQ42125056-F3DE555B-182E-4606-B432-6D2EC98C3558Q42880994-9788BC42-1604-4F47-9803-3C5D695F2172Q44051767-CCC0DF6E-D01D-450F-B4D4-120A0C7FA8A4Q44077554-755F3E80-FA0D-4E27-A1E1-8465B55E28D4Q44266319-5175AA7E-52C5-4764-9FA6-C15D582030BEQ46076171-2308145C-E47E-4A8D-818F-3CECF32C194F
P2860
Montelukast: a review of its therapeutic potential in persistent asthma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Montelukast: a review of its therapeutic potential in persistent asthma.
@ast
Montelukast: a review of its therapeutic potential in persistent asthma.
@en
type
label
Montelukast: a review of its therapeutic potential in persistent asthma.
@ast
Montelukast: a review of its therapeutic potential in persistent asthma.
@en
prefLabel
Montelukast: a review of its therapeutic potential in persistent asthma.
@ast
Montelukast: a review of its therapeutic potential in persistent asthma.
@en
P2860
P1433
P1476
Montelukast: a review of its therapeutic potential in persistent asthma.
@en
P2093
P2860
P304
P356
10.2165/00003495-200059040-00015
P577
2000-04-01T00:00:00Z
P6179
1003115732